Richard Levy
Director/Board Member at MADRIGAL PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jesse Shefferman | M | 52 | 7 years | |
| Herve Hoppenot | M | 64 | 10 years | |
| Paul Friedman | M | 81 | 8 years | |
| David Block | M | 64 |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 17 years |
| John Borgeson | M | 62 | 8 years | |
| Felix Baker | M | 55 | 9 years | |
| Rebecca Taub | M | 71 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 12 years |
| Victor Perlroth | M | 51 | 15 years | |
| Mark Ragosa | M | 50 | 6 years | |
| Jacqueline Zummo | M | 43 | 7 years | |
| Eben Tessari | M | 42 | 9 years | |
| Edward Chiang | M | - | 13 years | |
| James Daly | M | 63 | 9 years | |
| William Sibold | M | - | 1 years | |
| Sanj Patel | M | 54 | 9 years | |
| Fred Craves | M | 78 | 13 years | |
| Michael Megna | M | 53 | 6 years | |
| Luke Beshar | M | 65 | 6 years | |
| Barry Flannelly | M | 66 | 10 years | |
| Jane Huang | M | 51 | 3 years | |
| Ken Bate | M | 73 | 8 years | |
| Julian Baker | M | 57 | 1 years | |
| Gregory Sargen | M | 59 | 5 years | |
| Madelyn Zeylikman | F | - | 4 years | |
| Robert Profusek | M | 73 | 6 years | |
| Tracey McCain | F | 56 | 6 years | |
| Justine O'Malley | M | - | 4 years | |
| Thomas Tray | M | 46 | 19 years | |
| Tai Yin Yang | M | 70 | 5 years | |
| Roger Garceau | M | 70 | 5 years | |
| Cynthia Smith | F | 55 | 3 years | |
| Barry Quart | M | 67 | 9 years | |
| Charles Bancroft | M | 65 | 4 years | |
| Michael Solomon | M | 54 | 6 years | |
| Kim Popovits | F | 65 | 6 years | |
| G. Cole | M | 68 | 4 years | |
| Stephen Biggar | M | 53 | 9 years | |
| Jean-Jacques Bienaimé | M | 70 | 9 years | |
| Hannah Fry | F | 34 | 4 years | |
| Bassil Dahiyat | M | 53 | 6 years | |
| Mary J. Grendell | F | - | - | |
| Paul Clancy | M | 62 | 9 years | |
| Thomas Malley | M | 55 | 8 years | |
| Rachel Frank | F | - | - | |
| Robert Waltermire | M | 60 | 3 years | |
| Almas Qudrat | F | - | 6 years | |
| Kyle Rusconi | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 3 years |
| Carole Huntsman | F | - | - | |
| Pablo Velazquez-Martin | M | - | - | |
| Raymond Cheong | M | 42 | 1 years | |
| Ross Moat | M | 43 | 5 years | |
| Stephen Dodge | M | - | - | |
| Charles Polsky | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Mark Barrett | M | - | - | |
| Peter Langmuir | M | - | 9 years | |
| Martina Struck | M | - | 6 years | |
| Melissa Manno | F | - | 7 years | |
| Michael Morrissey | M | - | 8 years | |
| David Broser | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Tina Ventura | F | - | - | |
| Christopher Frates | M | - | 3 years | |
| Catalina Loveman | F | - | 9 years | |
| Steven Stein | M | 57 | 9 years | |
| John Paolini | M | 59 | 8 years | |
| Scott Strome | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Brian Lynch | M | 62 | 5 years | |
| Mark Lerner | M | - |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | 10 years |
| Raymond Schinazi | M | 74 |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | - |
| Ronald Filippo | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roy Whitfield | M | 70 | 23 years | |
| Richard de Schutter | M | 83 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 14 years |
| Thomas Beetham | M | 55 | 6 years | |
| Christopher Heberlig | M | 49 | 5 years | |
| Scott Braunstein | M | 60 | 2 years | |
| Marc R. Schneebaum | M | 69 | 7 years | |
| Stephen Mahoney | M | 53 | 4 years | |
| Lloyd Mackenzie | M | 56 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 10 years |
| Laurent Chardonnet | M | 59 | - | |
| Bryant Lim | M | 53 | 4 years | |
| Krishna Vaddi | M | 58 | 13 years | |
| Paul Trower | M | 54 | 18 years | |
| Eric Siegel | M | 60 | - | |
| Shelley McCloskey | F | 64 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Blaine Davis | M | 50 | 2 years | |
| Alex Howarth | M | 55 | 3 years | |
| David Milligan | M | 83 | 7 years | |
| Scott W. Hurley | M | 65 | - | |
| Joseph Papa | M | 68 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Sean Nolan | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 4 years |
| Barry Michael Ariko | M | 78 | 14 years | |
| David Hastings | M | 62 | 11 years | |
| Elias Bendekgey | M | 66 | 6 years | |
| Michael D. Casey | M | 78 | 17 years | |
| John F. Niblack | M | 85 | - | |
| Barbara Troupin | M | 56 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Carsten Boess | M | 57 | 5 years | |
| Patricia A. Schreck | F | 70 | 8 years | |
| Wendy Dixon | M | 68 | 12 years | |
| Ashley Garry | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.96% |
| Canada | 4 | 4.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Levy
- Personal Network
